1513-DMIa and 1513-DMIb, DNA methyltransferase inhibitors produced by Streptomyces sp. strain No. 1513

K Nagao1, K Suzuki, S Hamada

  • 1Laboratory of Medicinal Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

Insights

Two novel methyltransferase inhibitors, 1513-DMIa and 1513-DMIb, were discovered from Streptomyces sp. strain No. 1513. These compounds exhibit pH- and temperature-dependent inhibition of M. EcoRI, acting uncompetitively against DNA and S-adenosylmethionine (SAM).

Area of Science:

  • Microbiology
  • Biochemistry
  • Natural Product Chemistry

Background:

  • Methyltransferases are crucial enzymes involved in various biological processes.
  • Inhibitors of methyltransferases have therapeutic potential.
  • Streptomyces species are prolific producers of bioactive secondary metabolites.

Purpose of the Study:

  • To isolate and characterize novel methyltransferase inhibitors from Streptomyces sp. strain No. 1513.
  • To investigate the properties and inhibitory mechanisms of the newly discovered compounds.

Main Methods:

  • Isolation of compounds from culture filtrate using standard chromatographic techniques.
  • Determination of molecular weights using Fast Atom Bombardment Mass Spectrometry (FAB-MS) and gel filtration.
  • Enzyme inhibition assays to determine the mode of inhibition against M. EcoRI.

Main Results:

  • Two new methyltransferase inhibitors, 1513-DMIa and 1513-DMIb, were identified.
  • Molecular weights were estimated at 576 (1513-DMIa) and 8400 (1513-DMIb).
  • Inhibitory activity was dependent on pH and temperature, with uncompetitive inhibition observed against M. EcoRI concerning DNA and S-adenosylmethionine (SAM).

Conclusions:

  • 1513-DMIa and 1513-DMIb represent novel methyltransferase inhibitors with distinct properties.
  • The uncompetitive inhibition mechanism provides insights into enzyme-inhibitor interactions.
  • These compounds warrant further investigation for their potential applications.

Related Concept Videos